Deviance-elicited changes in event-related potentials are attenuated by ketamine in mice

被引:119
作者
Ehrlichman, Richard S. [1 ]
Maxwell, Christina R. [1 ]
Majumdar, Sonalee [1 ]
Siegel, Steven J. [1 ]
机构
[1] Univ Penn, Translat Res Labs, Dept Psychiat,Div Neuropsychiat, Stanley Ctr Expt Therapeut Psychiat, Philadelphia, PA 19104 USA
关键词
D O I
10.1162/jocn.2008.20097
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: People with schizophrenia exhibit reduced ability to detect change in the auditory environment, which has been linked to abnormalities in N-methyl-D-aspartate (NMDA) receptor-mediated glutamate neurotransmission. This ability to detect changes in stimulus qualities can be measured with electroencephalography using auditory event-related potentials (ERPs). For example, reductions in the N100 and mismatch negativity (MMN), in response to pitch deviance, have been proposed as endophenotypes of schizophrenia. This study examines a novel rodent model of impaired pitch deviance detection in mice using the NMDA receptor antagonist ketamine. Methods: ERPs were recorded from unanesthetized mice during a pitch deviance paradigm prior to and following ketamine administration. First, N40 amplitude was evaluated using stimuli between 4 and 10 kHz to assess the amplitude of responses across the frequency range used. The amplitude and latency of the N40 were analyzed following standard (7 kHz) and deviant (5-9 kHz) stimuli. Additionally, we examined which portions of the ERP are selectively altered by pitch deviance to define possible regions for the mouse MMN. Results: Mice displayed increased N40 amplitude that was followed by a later negative component between 50 and 75 msec in response to deviant stimuli. Both the increased N40 and the late N40 negativity were attenuated by ketamine. Ketamine increased N40 latency for both standard and deviant stimuli alike. Conclusions: The mouse N40 and a subsequent temporal region have deviance response properties similar to the human N100 and, possibly, MMN. Deviance responses were abolished by ketamine, suggesting that ketamine-induced changes in mice mimic deviance detection deficits in schizophrenia.
引用
收藏
页码:1403 / 1414
页数:12
相关论文
共 81 条
[1]   NEUROPHYSIOLOGICAL STUDIES OF SENSORY GATING IN RATS - EFFECTS OF AMPHETAMINE, PHENCYCLIDINE, AND HALOPERIDOL [J].
ADLER, LE ;
ROSE, G ;
FREEDMAN, R .
BIOLOGICAL PSYCHIATRY, 1986, 21 (8-9) :787-798
[2]  
ADLER LE, 1993, AM J PSYCHIAT, V150, P1856
[3]   Inherited auditory-cortical dysfunction in twin pairs discordant for schizophrenia [J].
Ahveninen, Jyrki ;
Jaaskelainen, Iiro P. ;
Osipova, Daria ;
Huttunen, Matti O. ;
Ilmoniemi, Risto J. ;
Kaprio, Jaakko ;
Lonnqvist, Jouko ;
Manninen, Marko ;
Pakarinen, Satu ;
Therman, Sebastian ;
Naatanen, Risto ;
Cannon, Tyrone D. .
BIOLOGICAL PSYCHIATRY, 2006, 60 (06) :612-620
[4]   Complex independent component analysis of frequency-domain electroencephalographic data [J].
Anemüller, J ;
Sejnowski, TJ ;
Makeig, S .
NEURAL NETWORKS, 2003, 16 (09) :1311-1323
[5]   Event-related oscillations are 'real brain responses' -: wavelet analysis and new strategies [J].
Basar, E ;
Schürmann, M ;
Demiralp, T ;
Basar-Eroglu, C ;
Ademoglu, A .
INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY, 2001, 39 (2-3) :91-127
[6]   Comparison of four components of sensory gating in schizophrenia and normal subjects: a preliminary report [J].
Boutros, NN ;
Belger, A ;
Campbell, D ;
D'Souza, C ;
Krystal, J .
PSYCHIATRY RESEARCH, 1999, 88 (02) :119-130
[7]   Morphological and latency abnormalities of the mid-latency auditory evoked responses in schizophrenia: a preliminary report [J].
Boutros, NN ;
Korzyuko, O ;
Oliwa, G ;
Feingold, A ;
Campbell, D ;
McClain-Furmanski, D ;
Struve, F ;
Jansen, BH .
SCHIZOPHRENIA RESEARCH, 2004, 70 (2-3) :303-313
[8]   Mismatch negativity in schizophrenia: a family study [J].
Bramon, E ;
Croft, RJ ;
McDonald, C ;
Virdi, GK ;
Gruzelier, JG ;
Baldeweg, T ;
Sham, PC ;
Frangou, S ;
Murray, RM .
SCHIZOPHRENIA RESEARCH, 2004, 67 (01) :1-10
[9]   Misattribution of sensory input reflected in dysfunctional target: non-target ERPs in schizophrenia [J].
Brown, K ;
Gordon, E ;
Williams, L ;
Bahramali, H ;
Harris, A ;
Gray, J ;
Gonsalvez, C ;
Meares, R .
PSYCHOLOGICAL MEDICINE, 2000, 30 (06) :1443-1449
[10]  
CATTS SV, 1995, AM J PSYCHIAT, V152, P213